Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$165.16 USD

165.16
1,260,775

+2.39 (1.47%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $165.19 +0.03 (0.02%) 7:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (42 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Abhinab Dasgupta headshot

Beat the Market Like Zacks: Novo Nordisk, Microsoft, Clorox in Focus

by Abhinab Dasgupta

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Sanghamitra Saha headshot

5 Top Stocks Likely to Exceed Earnings Estimates

by Sanghamitra Saha

These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Clorox (CLX), Coty (COTY), Yum China (YUMC), Terex (TEX) and Martin Marietta Materials (MLM).

Nalak Das headshot

5 Dividend-Paying Growth Stocks to Buy for a Stable Portfolio

by Nalak Das

We have narrowed our search to five dividend -paying growth stocks that have solid upside left for 2023. These are: CLX, ATR, MCD, ROL and GPK.

Here's Why You Should Invest in Clorox (CLX) Right Away

by Zacks Equity Research

Despite inflation concerns, Clorox (CLX) looks well-poised to drive growth in the future on the back of solid demand, pricing actions, cost-saving efforts and other growth strategies.

Best Growth Stocks to Buy for May 10th

by Zacks Equity Research

GPK, PHM and CLX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 10, 2023.

Best Growth Stocks to Buy for May 8th

by Zacks Equity Research

GPK, EZPW and CLX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 8, 2023.

Clorox (CLX) Beats Q3 Earnings & Sales Estimates, Ups View

by Zacks Equity Research

Clorox's (CLX) Q3 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.

Clorox (CLX) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 25.83% and 4.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

What Awaits The Estee Lauder Companies (EL) in Q3 Earnings?

by Zacks Equity Research

The Estee Lauder Companies' (EL) third-quarter fiscal 2023 performance is likely to reflect adverse impacts from inflation and supply-chain bottlenecks. Also, unfavorable currency rates are a concern.

Factors to Consider Ahead of Nu Skin's (NUS) Q1 Earnings

by Zacks Equity Research

Nu Skin's (NUS) first-quarter performance is likely to reflect macro headwinds like prolonged COVID-related disruptions, unfavorable currency rates and global inflation.

Has Clorox (CLX) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Here is how Clorox (CLX) and General Mills (GIS) have performed compared to their sector so far this year.

Colgate-Palmolive (CL) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.29% and 3.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Sysco Corporation (SYY) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Sysco (SYY) third-quarter results might reflect gains from the improving supply-chain efforts, and customer-oriented merchandising and marketing solutions.

Here's Why Clorox (CLX) Looks Well-Placed for Q3 Earnings Beat

by Zacks Equity Research

Clorox's (CLX) Q3 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.

Here's How Colgate (CL) is Poised Ahead of Q1 Earnings

by Zacks Equity Research

Colgate's (CL) first-quarter 2023 sales are likely to have gained from innovation, brand strength, focus on premiumization and expansion efforts.

Clorox (CLX) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abhinab Dasgupta headshot

Beat the Market Like Zacks: NVIDIA, Clorox, Procter & Gamble in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Will Clorox (CLX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: NVIDIA, Novo Nordisk, Magenta in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Here's Why Investors Should Hold Colgate (CL) Stock for Now

by Zacks Equity Research

Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.

Clorox (CLX) is a Top-Ranked Momentum Stock: Should You Buy?

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Abhinab Dasgupta headshot

Beat the Market Like Zacks: NVIDIA, SoundHound, Reuters in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?

by Zacks Equity Research

Here is how Clorox (CLX) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.

Clorox (CLX) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Clorox (CLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Industry Outlook Highlights The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox

by Zacks Equity Research

The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox are part of the Zacks Industry Outlook article.